Boehringer Ingelheim Pharmaceuticals
Manufacturing · Connecticut, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
900 Ridgebury Rd, Ridgefield, Connecticu...Phone Number
(800) 243-0127Revenue
$271.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Boehringer Ingelheim Pharmaceuticals
Boehringer Ingelheim USA Corporation is a leading pharmaceutical company dedicated to improving human and animal health through innovative research and development. With a strong presence in the United States, Boehringer Ingelheim USA focuses on delivering cutting-edge medicines and healthcare solutions that address a wide range of medical needs.Explore more
Popular SearchesBoehringer Ingelheim USA CorpBoehringer Ingelheim Pharma GmbH & Co KGBoehringer Ingelheim USAboehringer ingelheim us CorpBoehringer Ingelheim Pharmaceuticals, IncSIC Code 28,283NAICS Code 32,325Show moreBoehringer Ingelheim Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Boehringer Ingelheim Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Boehringer Ingelheim Pharmaceuticals recently announced quarterly report
Click to see if Boehringer Ingelheim Pharmaceuticals had a recent Job posting/layoffs
Check if Boehringer Ingelheim Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Boehringer Ingelheim Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Boehringer Ingelheim Pharmaceuticals
Check out if Boehringer Ingelheim Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Boehringer Ingelheim Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Boehringer Ingelheim Pharmaceuticals has new funding data
Recommended Actions
Reach out to Masked Content who joined Boehringer Ingelheim Pharmaceuticals as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Boehringer Ingelheim Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Boehringer Ingelheim Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Boehringer Ingelheim Pharmaceuticals.
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Industry Software
Event
Product Marketing, Events, Research & Development, Medical Research, Clinical Operations, Healthcare Technology
Boehringer Ingelheim Pharmaceuticals News & Media
Boehringer Ingelheim CARES Foundation Ignites a Brighter Future in Vet Med with a $500,000 Scholarship Pledge to Tuskegee University College of Veterinary Medicine
DULUTH, Ga., June 12, 2024 /PRNewswire/ -- The Boehringer Ingelheim CARES Foundation, an independent nonprofit organization, is lighting the path to a more diverse future in veterinary medicine with a pledge of $500,000 in scholarship funds to the Tuskegee University College of Veterinary...Delaware judge lets more than 70,000 Zantac lawsuits go forward
The ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a setback for former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim, which had argued that the expert witnesses' opinions lacked scientific support. “This moves us one step closer to justice for our clients,” Brent Wisner, one of the plaintiffs' lead lawyers, said in a statement on Saturday.New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
RIDGEFIELD, CT, May 16, 2024 - (ACN Newswire) - XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. This research team's main objective is to develop complex, physiologically relevant disease models that deepen our understanding of dysfunctional wound healing and fibrosis. The end goal is to study fibrosis, drug delivery strategies, and drug safety in parallel, in anBoehringer Ingelheim expands access to Humira biosimilar
Boehringer Ingelheim will manufacture adalimumab-adbm for Quallent Pharmaceuticals.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Boehringer Ingelheim Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Boehringer Ingelheim USA Corporation is a leading pharmaceutical company dedicated to improving human and animal health through innovative research and development. With a strong presence in the United States, Boehringer Ingelheim USA focuses on delivering cutting-edge medicines and healthcare solutions that address a wide range of medical needs.... Read More
